These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 25847

  • 1. Antihypertensive effect of trimepranol, a new beta-blocking agent.
    Jounela AJ, Pentikäinen PJ, Neuvonen PJ.
    Int J Clin Pharmacol Biopharm; 1978 Apr; 16(4):183-8. PubMed ID: 25847
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ, Leibowitz MT, Weinstein SP, Rowe ED, Mendel CM, Levy B, McMahon FG, Mullican WS, Toth PD, Cutler NR.
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [Abstract] [Full Text] [Related]

  • 3. Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents.
    Lyngstam O, Rydén L.
    Acta Med Scand; 1981 Jan; 209(4):261-6. PubMed ID: 7015797
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Propranolol-hydralazine combination in essential hypertension.
    Stevens JD, Binstok G, Mullane JF, Woods JW, Pittman AW, del Greco F, Huang C, Morledge JH.
    Clin Ther; 1983 Jan; 5(5):525-39. PubMed ID: 6352036
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Assessment of beta-blocking activity of trimepranol in man.
    Pentikäinen PJ, Neuvonen PJ, Penttilä A.
    Int J Clin Pharmacol Biopharm; 1978 Jun; 16(6):279-84. PubMed ID: 27464
    [Abstract] [Full Text] [Related]

  • 9. Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product.
    White WB, Lacourciere Y, Gana T, Pascual MG, Smith DH, Albert KS.
    Am Heart J; 2004 Oct; 148(4):628-34. PubMed ID: 15459593
    [Abstract] [Full Text] [Related]

  • 10. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM, Chamontin B, Asmar R, De Leeuw PW, O'Brien E, Duprez D, O'Rourke MF, Rahn KH, Romero R, Battegay E, Hitzenberger G, Safar ME, REASON Project.
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [Abstract] [Full Text] [Related]

  • 11. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.
    Papademetriou V, Hainer JW, Sugg J, Munzer D, ATTACH Study Group.
    Am J Hypertens; 2006 Dec; 19(12):1217-25. PubMed ID: 17161766
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Felodipine versus prazosin as an addition to a beta-blocker in the treatment of essential hypertension. The Australian Multicentre Study.
    Jackson B, Morgan TO, Gibson J, Anderson A.
    Drugs; 1987 Dec; 34 Suppl 3():109-19. PubMed ID: 2894971
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical pharmacology of trimepranol (pharmacokinetic informations and effects on heart rate in healthy individuals)].
    Mayer O, Petrlík M, Vitous J, Cepelák V.
    Vnitr Lek; 1976 Nov; 22(11):1102-9. PubMed ID: 12612
    [No Abstract] [Full Text] [Related]

  • 17. Celiprolol in systemic hypertension.
    Frishman WH, Flamenbaum W, Schoenberger J, Schwartz GL, Vidt DG, Neri GS, Greenberg S, Lazar E, Godfrey JC, Stevenson A.
    Am J Cardiol; 1989 Apr 01; 63(12):839-42. PubMed ID: 2522723
    [Abstract] [Full Text] [Related]

  • 18. Antihypertensive therapy with once-daily administration of terazosin, a new alpha 1-adrenergic-receptor blocker.
    Abraham PA, Halstenson CE, Matzke GR, Napier JL, Keane WF.
    Pharmacotherapy; 1985 Apr 01; 5(5):285-9. PubMed ID: 2866492
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of carvedilol in the treatment of hypertension.
    Schnurr E, Widmann L, Glocke M.
    J Cardiovasc Pharmacol; 1987 Apr 01; 10 Suppl 11():S101-7. PubMed ID: 2454354
    [Abstract] [Full Text] [Related]

  • 20. Bevantolol vs propranolol: a double-blind controlled trial in essential hypertension.
    Maclean D.
    Angiology; 1988 Jun 01; 39(6):487-96. PubMed ID: 2897812
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.